GlassScriptPhysician profile
Omer Kineish
NPI 1730575663
$3,742.92
in general payments reported to CMS, 2019-2025
32 companies · $25.96 in 2025
The $25.96 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54.72 · 2020: $102 · 2021: $1,554 · 2022: $1,474 · 2023: $391 · 2024: $140 · 2025: $25.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $557.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $557.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rochester Medical Corporation | $509.08 | 2021 | |
| Abbvie INC. | $350.19 | 2021-2024 | |
| Janssen Biotech, INC. | $346.18 | 2022-2024 | Erleada |
| Boston Scientific Corporation | $274.23 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $249.70 | 2022-2025 | Myrisk |
| Endo Pharmaceuticals INC. | $234.68 | 2021-2022 | |
| Astellas Pharma US INC | $181.38 | 2021-2023 | Xtandi, Myrbetriq |
| Pfizer INC. | $150.96 | 2021-2023 | |
| Antares Pharma, INC. | $150.45 | 2021-2023 | Xyosted, Nocdurna, Tlando |
| Terumo Medical Corporation | $139.62 | 2022 | |
| Integra Lifesciences Corporation | $118.41 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $110.64 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $96.72 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $92.08 | 2020-2021 | |
| Mission Pharmacal Company | $88.18 | 2022-2024 | Uribel, Uribel Tabs |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $86.08 | 2022 | |
| Amniox Medical, INC. | $85.50 | 2020 | |
| Myovant Sciences INC. | $76.20 | 2021-2022 | |
| Convatec INC. | $58.04 | 2022-2024 | |
| Coloplast Corp | $54.72 | 2019 | |
| Telix Pharmaceuticals | $40.36 | 2022-2023 | Illuccix |
| Biotissue Holdings INC. | $31.13 | 2022 | |
| Acerus Pharmaceuticals Corporation | $29.86 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $29.72 | 2023 | Orgovyx |
| Abc Home Medical Supply, INC. | $23.65 | 2022 | |
| Progenics Pharmaceuticals, INC. | $23.03 | 2022 | |
| Blue Earth Diagnostics | $21.51 | 2021 | |
| C. R. Bard, INC. & Subsidiaries | $20.83 | 2022 | |
| Clarus Therapeutics INC. | $20.44 | 2021 | |
| Merck Sharp & Dohme LLC | $19.32 | 2022 | |
| Olympus America INC. | $15.57 | 2021 | |
| Teleflex LLC | $14.46 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omer Kineish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.